SG/PUT/AMGEN/350/0.1/20.06.25 Share Price

DE000SY2DJY0

Real-time Boerse Frankfurt Warrants 17:49:34 05/07/2024 BST
4.91 ^EUR	-2.19%

Current month

+3.29%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints	07-02	MT
Amgen Inc.(NasdaqGS:AMGN) added to Russell 1000 Dynamic Index	06-30	CI
Argus Raises Amgen's Price Target to $340 From $300	06-27	MT
Amgen CEO Bob Bradway’s Advice to Amgen’s Summer Interns: Don’t Hold Back	06-27	PU

More news

Quotes 5-day view

Date	Price	Change
05/07/24	4.91	-2.19%
04/07/24	5.02	+0.40%
03/07/24	5	+1.21%
02/07/24	4.94	-0.20%
01/07/24	4.95	+1.85%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 05:49 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	AMGEN INC.
Issuer	Société Générale
WKN	SY2DJY
ISIN	DE000SY2DJY0
Date issued	27/06/2024
Strike	350 $
Maturity	20/06/2025 (350 Days)
Parity	10 : 1
Emission price	4.57 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	5.14 €
Lowest since issue	4.52 €
Spread	0.03 €
Spread %	0.60%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company